The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Colorectal cancer: From prevention to personalized medicine
Open accessAbstract
Colorectal cancer (CRC) is a very heterogeneous disease that is caused by the interaction of genetic and environmental factors. CRC develops through a gradual accumulation of genetic and epigenetic changes, leading to the transformation of normal colonic mucosa into invasive cancer. CRC is one of the most prevalent and incident cancers worldwide, as well as one of the most deadly. Approximately 1235108 people are diagnosed annually with CRC, and 609051 die from CRC annually. The World Health Organization estimates an increase of 77% in the number of newly diagnosed cases of CRC and an increase of 80% in deaths from CRC by 2030. The incidence of CRC can benefit from different strategies depending on its stage: health promotion through health education campaigns (when the disease is not yet present), the implementation of screening programs (for detection of the disease in its early stages), and the development of nearly personalized treatments according to both patient characteristics (age, sex) and the cancer itself (gene expression). Although there are different strategies for screening and although the number of such strategies is increasing due to the potential of emerging technologies in molecular marker application, not all strategies meet the criteria required for screening tests in population programs; the three most accepted tests are the fecal occult blood test (FOBT), colonoscopy and sigmoidoscopy. FOBT is the most used method for CRC screening worldwide and is also the primary choice in most population-based screening programs in Europe. Due to its non-invasive nature and low cost, it is one of the most accepted techniques by population. CRC is a very heterogeneous disease, and with a few exceptions (APC, p53, KRAS), most of the genes involved in CRC are observed in a small percentage of cases. The design of genetic and epigenetic marker panels that are able to provide maximum coverage in the diagnosis of colorectal neoplasia seems a reasonable strategy. In recent years, the use of DNA, RNA and protein markers in different biological samples has been explored as strategies for CRC diagnosis. Although there is not yet sufficient evidence to recommend the analysis of biomarkers such as DNA, RNA or proteins in the blood or stool, it is likely that given the quick progression of technology tools in molecular biology, increasingly sensitive and less expensive, these tools will gradually be employed in clinical practice and will likely be developed in mass.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–236 of 236
Karl, J., Wild, N., Tacke, M., Andres, H. H., Garczarek, U., Rollinger, W., & Zolg, W. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.04.021 · Cited by 73
Proteomic profiling of urine for the detection of colon cancer
Ward, D. G., Nyangoma, S., Joy, H., Hamilton, E., Wei, W., Tselepis, C., Steven, N. M., Wakelam, M. J. O., Johnson, P. J., Ismail, T., et al. (2008) · Proteome Science · doi:10.1186/1477-5956-6-19 · Cited by 73
Colorectal Cancer Screening using Immunochemical Faecal Occult Blood Testing in Japan
Saito, H. (2006) · Journal of Medical Screening · doi:10.1177/0969141306013001s03 · Cited by 72
Kanaoka, S., Yoshida, K., Miura, N., Sugimura, H., & Kajimura, M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.022 · Cited by 68
DNA Stabilization Is Critical for Maximizing Performance of Fecal DNA-Based Colorectal Cancer Tests
Olson, J., Whitney, D. H., Durkee, K. H., & Shuber, A. P. (2005) · Diagnostic Molecular Pathology · doi:10.1097/01.pas.0000176768.18423.7e · Cited by 62
Novel Methylation Panel for the Early Detection of Colorectal Tumors in Stool DNA
Azuara, D., Rodríguez‐Moranta, F., de, J., Soriano-Izquierdo, A., Móra, J., Guardiola, J., Biondo, S., Blanco, I., Peinado, M. A., Moreno, V. R., et al. (2010) · Clinical Colorectal Cancer · doi:10.3816/ccc.2010.n.023 · Cited by 62
Lynge, E. (2002) · PubMed · Cited by 62
Detection of Hypermethylated Vimentin in Urine of Patients with Colorectal Cancer
Song, B. P., Jain, S., Lin, S. Y., Chen, Q., Block, T. M., Song, W., Brenner, D. E., & Su, Y. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.12.003 · Cited by 60
Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts
Bezabeh, T., Somorjai, R. L., Dolenko, B., Bryskina, N., Levin, B., Bernstein, C. N., Jeyarajah, E. J., Steinhart, A. H., Rubin, D. T., & Smith, I. C. P. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1372 · Cited by 58
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
Day, R. W., Wandell, M., Blumenstein, B. A., Rösch, T., Ransohoff, D. F., Payne, S. R., Castaños‐Vélez, E., Snover, D. C., Lofton–Day, C., Burger, M., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/n4c0-4d86 · Cited by 58
Takai, T., Kanaoka, S., Yoshida, K., Hamaya, Y., Ikuma, M., Miura, N., Sugimura, H., Kajimura, M., & Hishida, A. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0937 · Cited by 57
Ausch, C., Kim, Y.-H., Tsuchiya, K. D., Dzieciatkowski, S., Washington, M. K., Paraskeva, C., Radich, J. P., & Grady, W. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.122937 · Cited by 56
Bosch, L. J. W., Oort, F. A., Neerincx, M., Bakker, C. A. J. K.-D., Droste, J. S. T. S., Melotte, V., Jonkers, D. M. A. E., Masclee, A., Mongera, S., Grooteclaes, M., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0315 · Cited by 55
Lindsetmo, R. O., Joh, Y. G., & Delaney, C. P. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3281 · Cited by 54
Prall (2009) · International Journal of Oncology · doi:10.3892/ijo_00000343 · Cited by 50
von Wagner, C., Ghanouni, A., Halligan, S., Smith, S. G., Dadswell, E., Lilford, R. J., Morton, D. G., Atkin, W. S., & Wardle, J. (2012) · Radiology · doi:10.1148/radiol.12111523 · Cited by 50
Cytoskeletal agents inhibit motility and adherence of human tumor cells
Stracke, M. L., Soroush, M., Liotta, L. A., & Schiffmann, E. (1993) · Kidney International · doi:10.1038/ki.1993.25 · Cited by 46
Detection of a K-ras mutation in urine of patients with colorectal cancer
Su, Y., Wang, M., Aiamkitsumrit, B., Brenner, D. E., & Block, T. M. (2005) · Cancer Biomarkers · doi:10.3233/cbm-2005-12-305 · Cited by 43
Zhang, J., Shaobin, Y., Xie, Y., Chen, X., Zhao, Y., He, D., & Li, J. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.04.006 · Cited by 43
Capecitabine as Adjuvant Treatment for Stage III Colon Cancer
Kochman, M. L. (2006) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70320-9 · Cited by 37
Clinical Significance of Small Polyps Found During Screening with Flexible Sigmoidoscopy
Farraye, F. A., & Wallace, M. B. (2002) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/s1052-5157(03)00056-4 · Cited by 33
Zhang, H., Song, Y., & Dang, C. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.5278 · Cited by 33
Colorectal cancer mortality in Spain: trends and projections for 1985–2019
Ribes, J., Navarro, M., Clèries, R., Esteban, L., Pareja, L., Binefa, G., Peris, M., Fernández, E., & Borràs, J. M. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32830b5f39 · Cited by 31
Self-citationPrognostic and Diagnostic Value of Spontaneous Tumor‐Related Antibodies
Kobold, S., Luetkens, T., Cao, Y., Bokemeyer, C., & Atanackovic, D. (2010) · Journal of Immunology Research · doi:10.1155/2010/721531 · Cited by 31
Scheitel, S. M., Ahlquist, D. A., Wollan, P. C., et al. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.12.1207 · Cited by 31
Wang, Q., Shen, J., Li, Z.-F., Jie, J., Wang, W., Wang, J., Zhang, Z., Li, Z., Yan, L., & Gu, J. F. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-287 · Cited by 29
False-positive results from colorectal cancer screening in Catalonia (Spain), 2000–2010
García, M., Milà, N., Binefa, G., Borràs, J. M., Espinàs, J. A., & Moreno, V. R. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012013 · Cited by 27
Self-citationIdentification of Cancer Autoantigens in Serum: Toward Diagnostic/Prognostic Testing?
Casal, J. I., & Barderas, R. (2010) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256367 · Cited by 26
Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer
Lu, H., Goodell, V., & Disis, M. L. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.2.235 · Cited by 26
Calistri, D., Rengucci, C., Gardini, A. C., Frassineti, G. L., Scarpi, E., Zoli, W., Falcini, F., Silvestrini, R., & Amadori, D. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0291 · Cited by 24
Detection and Quantification of Mutations in the Plasma of Patients With Colorectal Tumors
Kochman, M. L. (2006) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70319-2 · Cited by 23
Medina, G. G., McQueen, A., Greisinger, A. J., Bartholomew, L. K., & Vernon, S. W. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/895807 · Cited by 22
Japink, D., Leers, M. P. G., Sosef, M. N., & Nap, M. (2009) · PubMed · Cited by 22
Chapter 2 Urinary Markers in Colorectal Cancer
Feng, B., Yue, F., & Zheng, M. (2009) · Advances in clinical chemistry · doi:10.1016/s0065-2423(09)47002-1 · Cited by 16
Defining Quality in Colon Cancer Surgery
Madoff, R. D. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.9615 · Cited by 15
Borràs, J. M., Pareja, L., Peris, M., & Espinàs, J. A. (2008) · Medicina Clínica · doi:10.1016/s0025-7753(08)76435-2 · Cited by 11
Cited by
Colorectal cancer development and advances in screening
Balchen, V., & Simon, K. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s109285 · Cited by 665
Dalmasso, G., Cougnoux, A., Delmas, J., Darfeuille-Michaud, A., & Bonnet, R. (2014) · Gut Microbes · doi:10.4161/19490976.2014.969989 · Cited by 296
“Increasing numbers of molecular biomarkers of the tumor and the pharmacogenomic profile of the patient are therefore taken into account when selecting the appropriate chemotherapy.(26) This paradigm of personalized treatment for anticancer chemotherapy may be extended in the future by taking into account the contribut…”
BackgroundDiagnostic Accuracy of CT for Local Staging of Colon Cancer: A Systematic Review and Meta-Analysis
Nerad, E., Lahaye, M. J., Maas, M., Nelemans, P., Bakers, F. C. H., Beets, G. L., & Beets-Tan, R. G. H. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.15.15785 · Cited by 255
Thomas, A. M., Jesus, E. C., Lopes, A., Aguiar, S., Begnami, M. D., Rocha, R. M., Carpinetti, P. A., Camargo, A. A., Hoffmann, C., Freitas, H. C., et al. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00179 · Cited by 136
Liu, B., & Wang, H. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11321 · Cited by 56
Metadata
- Authors
- Binefa, G.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 20
- Issue
- 22
- Pages
- 6786
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2065434214
- Cited by
- 382
- References
- 236
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.